ORTHO-LEFLUNOMIDE (25 mg) (N-(2'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)

ORTHO-LEFLUNOMIDE (25 mg) (N-(2′-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)

In Stock

Ready to ship

Catalogue No.

1A06120

CAS No.

1403564-06-6

Molecular Formula

C₁₂H₉F₃N₂O₂

Product Type

Pharmaceutical Analytical Impurities

$650.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F231X0

Harmonized System (HS) Code *:

29349910

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₁₂H₉F₃N₂O₂

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F231X0	1A06120-F231X0	See Product Information Sheet	India	Chemical Synthesis


Lot No F231X0	USP Certificates/Product Information Sheets and Valid Use Dates Chemical Synthesis
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* No data available

Lot No

F231X0

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

ORTHO-LEFLUNOMIDE (25 mg) (N-(2'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)

Catalogue No.

1A06120

CAS No.

1403564-06-6

Molecular Formula

C₁₂H₉F₃N₂O₂

Product Type

Pharmaceutical Analytical Impurities

$650.00

DIDEHYDROGLYCOPYRROLATE (25 mg) (3-[2-(Cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide)

Catalogue No.

1A10070

CAS No.

Molecular Formula

C₁₉H₂₆BrNO₃

Product Type

Pharmaceutical Analytical Impurities

$1,025.00

RIZATRIPTAN N-METHYL ADDUCT IODIDE (25 mg) (2-{5-[(1H-1,2,4-Triazol-1-yl)methyl]-1H-indol-3-yl}-N,N,N-trimethylethan-1-aminium iodide)

Catalogue No.

1A10050

CAS No.

Molecular Formula

C₁₆H₂₂IN₅

Product Type

Pharmaceutical Analytical Impurities

$690.00

GUANOSINE (25 mg) (2-Amino-9-β-D-ribofuranosylpurine-6(1H)-one)

1-HYDROXY-2-NAPHTHOIC ACID (25 mg) (1-Hydroxy-naphthalene-2-carboxylic acid)

DIDEHYDROGLYCOPYRROLATE (25 mg) (3-[2-(Cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide)

PIVALOYL PHENYLGLYCINE (25 mg) ((R)-2-Phenyl-2-pivalamidoacetic acid)

SULFAGUANIDINE (25 mg) (4-Amino-N-carbamimidoylbenzenesulfonamide)

17α-HYDROXYPROGESTERONE (25 mg) (17-Hydroxypregn-4-ene-3,20-dione)

EPOXY BETAMETHASONE (25 mg) (9,11β-Epoxy-17,21-dihydroxy-16β-methyl-9β-pregna-1,4-diene-3,20-dione)

DIMETHYL FELODIPINE (25 mg) (Dimethyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate)

DESCHLORO DESLORATADINE HYDROCHLORIDE (25 mg) (6,11-Dihydro-11-(piperidin-4-ylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine hydrochloride)

O-ACETYL IOPAMIDOL (25 mg) ((S)-5-[[2-(acetyloxy)-1-oxopropyl]amino]-N,N′-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,3-Benzenedicarboxamide)